Register for streaming realtime charts, analysis tools, and prices.

Get Started

AGEN

Agenus (AGEN)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AGEN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next >>

Date	Time	Source	Headline	Symbol	Company
12/23/2022	4:08PM	Edgar (US Regulatory)	Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)	NASDAQ:AGEN	Agenus Inc
12/21/2022	8:30AM	GlobeNewswire Inc.	Agenus to Present Botensilimab Data at Late-Breaking Oral Session at ASCO-GI	NASDAQ:AGEN	Agenus Inc
12/02/2022	4:14PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGEN	Agenus Inc
11/17/2022	8:30AM	GlobeNewswire Inc.	Agenus Data at CTOS 2022 Highlight Durable Clinical Responses of Botensilimab / Balstilimab Combination in Advanced Sarcoma	NASDAQ:AGEN	Agenus Inc
11/16/2022	8:30AM	GlobeNewswire Inc.	Agenus to Participate at 5th Annual Evercore ISI HealthCONx Conference	NASDAQ:AGEN	Agenus Inc
11/14/2022	8:30AM	GlobeNewswire Inc.	Agenus Data at SITC 2022 Highlight Durable Responses of Botensilimab / Balstilimab Combination in Nine Different Treatment-Resistant Cancers	NASDAQ:AGEN	Agenus Inc
11/08/2022	8:01AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGEN	Agenus Inc
11/08/2022	8:00AM	GlobeNewswire Inc.	Agenus Provides Corporate Update and Third Quarter 2022 Financial Report	NASDAQ:AGEN	Agenus Inc
10/25/2022	8:30AM	GlobeNewswire Inc.	Agenus to Provide Corporate Update and Third Quarter 2022 Financial Report	NASDAQ:AGEN	Agenus Inc
10/13/2022	8:32AM	GlobeNewswire Inc.	GSK’s older adult RSV vaccine candidate, containing Agenus’ QS-21 STIMULON™, shows 94.1% reduction in severe RSV disease and overall vaccine efficacy of 82.6% in pivotal trial	NASDAQ:AGEN	Agenus Inc
10/12/2022	8:00AM	GlobeNewswire Inc.	VBI Vaccines and Agenus Announce Collaboration to Evaluate VBI-1901 in Combination with Anti-PD-1 Balstilimab in a Phase 2 Study in Primary Glioblastoma Patients	NASDAQ:AGEN	Agenus Inc
10/05/2022	1:11PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
10/05/2022	1:08PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
10/05/2022	8:30AM	GlobeNewswire Inc.	Agenus to Host “The Road Taken” R&D Event on November 12, 2022	NASDAQ:AGEN	Agenus Inc
10/05/2022	8:00AM	GlobeNewswire Inc.	Agenus to Present Botensilimab Data at a Plenary Session of the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting	NASDAQ:AGEN	Agenus Inc
09/12/2022	8:30AM	GlobeNewswire Inc.	Agenus Makes Senior Regulatory and Clinical Appointments	NASDAQ:AGEN	Agenus Inc
09/12/2022	8:30AM	GlobeNewswire Inc.	Agenus Initiates Botensilimab Phase 2 ACTIVATE Trials in Advanced MSS Colorectal Cancer and Advanced Melanoma	NASDAQ:AGEN	Agenus Inc
08/11/2022	4:40PM	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:AGEN	Agenus Inc
08/09/2022	1:05PM	TipRanks	B.Riley Financial Remains a Buy on Agenus (AGEN)	NASDAQ:AGEN	Agenus Inc
08/09/2022	8:00AM	GlobeNewswire Inc.	Agenus Provides Corporate Update and Second Quarter 2022 Financial Report	NASDAQ:AGEN	Agenus Inc
08/09/2022	7:57AM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AGEN	Agenus Inc
08/05/2022	4:16PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AGEN	Agenus Inc
08/02/2022	8:30AM	GlobeNewswire Inc.	Agenus to Participate at BTIG Biotechnology Conference	NASDAQ:AGEN	Agenus Inc
08/01/2022	8:30AM	GlobeNewswire Inc.	Agenus Announces First Patient Dosed in Phase 1 Study of AGEN1571 (anti-ILT2) in Advanced Solid Tumors	NASDAQ:AGEN	Agenus Inc
07/27/2022	8:30AM	GlobeNewswire Inc.	Agenus to Provide Corporate Update and Second Quarter 2022 Financial Report	NASDAQ:AGEN	Agenus Inc
07/06/2022	3:53PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
07/06/2022	3:52PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
07/06/2022	3:52PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
07/06/2022	3:50PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AGEN	Agenus Inc
07/02/2022	9:15AM	TipRanks	William Blair Thinks Agenus’ Stock is Going to Recover	NASDAQ:AGEN	Agenus Inc

Showing the most relevant articles for your search:NASDAQ:AGEN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next >>

Marketing Worldwide (PK)

Seafarer Exploration (PK)

Bell Buckle (PK)

Therapeutic Solutions (PK)

NioCorp Developments

Fannie Mae (QB)

Seven Arts Entertainment (PK)

Good Vibrations Shoes (PK)

Trump Media and Technology

Anavex Life Sciences

Brookmount Explorations (PK)

Kraig Biocraft Laborator... (QB)

Delayed Upgrade Clock